Tissue transglutaminase and factor XIII in cartilage and bone remodeling

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 5, 1996, Pages 437-443

  Aeschlimann, Daniel ^a,c   Mosher, Deane ^a   Paulsson, Mats ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c University of Wisconsin Health   (United States)

Author keywords

bone; cartilage; extracellular matrix; factor XIII; tissue transglutaminase

Indexed keywords

BLOOD CLOTTING FACTOR 13; COLLAGEN; FIBRILLIN; FIBRONECTIN; OSTEONECTIN; OSTEOPONTIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL TISSUE; BONE REMODELING; CARTILAGE; CELL DIFFERENTIATION; CROSS LINKING; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030450884     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999043     Document Type: Review

References (45)

1. Soloursh M: Differentiation of cartilage and bone. Curr Opin Cell Biol 1:989-994, 1989
2. Aeschlimann D, O Kaupp, M Paulsson: Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: Identification of osteonectin as a major glutaminyl substrate. J Cell Biol 129: 881-892, 1995.
3. Aeschlimann D, A Wetterwald, H Fleisch, M Paulsson: Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol 120:1461-1470, 1993.
4. Aeschlimann D, M Paulsson: Transglutaminases: Protein cross-linking enzymes in tissues and body fluids. Thromb Haemost 71: 402-415, 1994.
5. Lu S, M Saydak, V Gentile, JP Stein, PJA Davies: Isolation and characterization of the human tissue transglutaminase gene promoter. J Biol Chem 270:9748-9756, 1995.
6. Nagy L, PJA Davies: Retinoid regulated expression of tissue transglutaminase. (Abst.) Blood Coagul Fibrinol 6:337, 1995.
7. Ballock RT, A Heydemann, LM Wakefield, KC Flanders, AB Roberts. MB Sporn: Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-β. J Cell Physiol 159:340-346, 1994.
8. Iwamoto M, IM Shapiro, K Yagami, AL Boskey, PS Leboy, SL Adams, M Pacifici: Retinoic acid induces rapid mineralization and expression of mineralization-related genes in chondrocytes. Exp Cell Res 207:413-420, 1993.
9. Centrella M, MC Horowitz, JM Wozney, TL McCarthy: Transforming growth factor-β gene family members and bone. Endocr Rev 15:27-39, 1994.
10. Jones TH: Interleukin-6 an endocrine cytokine. Clin Endocrinol 40:703-713, 1994.
11. Murthy SNP, L Lorand: Cross-linked Aα-γ chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase. Proc Natl Acad Sci USA 87:9679-9682, 1990.
12. Shainoff JR, DA Urbanic, PM DiBello: Immunoelectrophoretic characterization of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. J Biol Chem 266:6429-6437, 1991.
13. Adany R, A Kiss, L Muszbek: Factor XIII: A marker of mono- and megakaryocytopoiesis. Br J Haematol 67:167-172, 1987.
14. Henriksson P, S Becker, G Lynch, J McDonagh: Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 76:528-534, 1985.
15. Poon M-C, JA Russell, S Low, GD Sinclair, AR Jones, W Blahey, BA Ruether, DI Hoar: Hemopoietic origin of factor XIII a-subunits in platelets, monocytes and plasma. Evidence from bone marrow transplantation studies. J Clin Invest 84:787-792, 1989.
16. Barry ELR, DF Mosher: Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. J Biol Chem 264:4179-4185, 1989.
17. Barry ELR, DF Mosher: Binding and degradation of blood coagulation factor XIII by cultured fibroblasts. J Biol Chem 265:9302-9307, 1990.
18. Claes L, C Burri, H Gerngross, W Mutschler: Bone healing stimulated by plasma factor XIII. Osteotomy experiments in sheep. Acta Orthop Scand 56:57-62, 1985.
19. Gerngross H, C Burri, L Claes: Experimental studies on the influence of fibrin adhesive, factor XIII, and calcitonin on the incorporation and remodelling of autologous bone grafts. Arch Orthop Trauma Surg 106:23-31, 1986.
20. Lane TF, EH Sage: The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8:163-173, 1994.
21. Timpl R, M Aumailley: Other basement membrane proteins and their calcium-binding potential. In: Rohrbach DH, R Timpl (Eds): Molecular and Cellular Aspects of Basement Membranes. Academic Press, Orlando, FL, 1993, pp 211-235.
22. Hohenadl C, K Mann, U Mayer, R Timpl, M Paulsson, D Aeschlimann: Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminase catalyzed modification. J Biol Chem 270:23415-2.3420, 1995.
23. Maurer P, C Hohenadl, E Hohenester, W Goehring, R Timpl, J Engel: The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. J Mol Biol 253:347-357, 1995.
24. Denhardt DT, X Guo: Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482, 1993.
25. Prince CW, D Dickie, CL Krumdieck: Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun 177:1205-1210, 1991.
26. Beninati S, DR Senger, E Cordella-Miele, AB Mukherjee, I Chackalaparampil, V Shanmugam, K Singh, BB Mukherjee: Osteopontin: Its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J Biochem 115:675-682, 1994.
27. Sorensen ES, LK Rasmussen, L Moller, PH Jensen, P Hojrup, TE Petersen: Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. Biochem J 304:13-16, 1994.
28. Mosher DF: Assembly of fibronectin into extracellular matrix. Curr Opin Struct Biol 3:214-222, 1993.
29. Martinez J, DG Chalupowicz, RK Roush, A Sheth, C Barsigian: Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 33:2538-2545, 1994.
30. McDonagh RP, J McDonagh, TE Petersen, HC Thogersen, K Skorstengaard, L Sottrup-Jensen, S Magnusson: Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin. FEBS Lett 127:174-178, 1981.
31. Fesus L, ML Metsis, L Muszbek, VE Koteliansky: Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. FEBS Lett 154:371-374, 1986.
32. Parumeswaran KN, PT Velasco, J Wilson, L Lorand: Labeling of ε-lysine cross-linking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc Natl Acad Sci USA 87:8472-8475, 1990.
33. Jeong JM, SNP Murthy, JT Radek, L Lorand: The fibronectin-binding domain of transglutaminase. J Biol Chem 270:5654-5658, 1995.
34. LeMosy EK, HP Erickson, WF Beyer, JT Radek, JM Jeong, SNP Murthy, L Lorand: Visualization of purified fibronectin-transglutaminase complexes. J Biol Chem 267:7880-7885, 1992.
35. Van der Rest M, R Garrone: Collagen family of proteins. FASEB J 5:2814-2823, 1991.
36. Kleman JP, D Aeschlimann, M Paulsson, M van der Rest: Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 34:13768-13775, 1995.
37. Bowness JM, JE Folk, R Timpl: Identification of a substrate for liver transglutaminase on the aminopropeptide of type III collagen. J Biol Chem 262:1022-1024, 1987.
38. Board PG, MS Losowsky, KJ Miloszewski: Factor XIII: Inherited and acquired deficiency. Blood Rev 7:229-242, 1993.
39. Martinowitz U, S Schulman: Fibrin sealant in surgery of patients with a hemorrhagic diathesis. Thromb Haemost 74:486-492, 1995.
40. McDonagh J: Hereditary and acquired deficiencies of activated factor XIII. In: Beutler E, MA Lichtman, BS Coller, TJ Kipps (Eds): Williams Hematology. McGraw-Hill, New York, 1995, pp 1455-1458.
41. Schlag G, H Redl: Fibrin sealant in orthopaedic surgery. Clin Orthop 227:269-285, 1988.
42. Joyce ME, AB Roberts, MB Sporn, ME Bolander: Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110:2195-2207, 1990.
43. Shapiro F, S Koide, MJ Glimcher: Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg 75A:532-553, 1993.
44. Juergensen K, D Aeschlimann, V Cavin, M Genge, EB Hunziker: A new biological glue for cartilage-cartilage interfaces: Tissue transglutaminase. J Bone Joint Surg, in press.
45. Ragunath M, T Baechi, D Aeschlimann, B Steinmann: 10-12nm microfibrils and their main component, fibrillin, are cross-linked by transglutaminase in dermal fibroblast cultures and human dermis. J Cell Sci, submitted for publication.